Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Product Launches To Plan For In 2020

May 30 2019

• By John Davis

Rocket — Launches need to be planned well in advance. • Source: Shutterstock

Related Content

WHO To Facilitate Rapid Roll Out Of Merck's Ebola Vaccine In Africa

May 28 2019

Genfit Hopes To Make Case For First-Line Treatment In NASH

Apr 04 2019

ViiV/Janssen's Long-Acting Anti-HIV Injections Impress

Aug 16 2018

Key Drug Launches To Plan For In 2019

Sep 03 2018

Biohaven Pays $105m For Turbo Boost In Migraine Drug Review Race

Mar 20 2019

Horizon Pharma Sees Mid-2019 BLA For Tepro After Solid Phase III TED Data

Mar 01 2019

Cystic Fibrosis Triplet Could Unblock EU Reimbursement Impasse

May 01 2019

Takeda Sees Strong Fundamentals Despite Post-Shire Loss Outlook

May 14 2019

Bluebird Lays Some New Eggs, But They'll Take Time To Hatch

May 16 2019

J&J Plans 10 Potential Blockbuster Filings By 2023

May 15 2019

Related Companies

GSK plc

Clovis Oncology, Inc.

Johnson & Johnson

MacroGenics, Inc.

Global Blood Therapeutics, Inc.

Novartis AG

Pfizer Inc.

Genetix Biotherapeutics

Acceleron Pharma, Inc.

AstraZeneca PLC

FibroGen, Inc.

Astellas Pharma, Inc.

Merck & Co., Inc.

Takeda Pharmaceutical Co. Ltd.

Sanofi

Bristol Myers Squibb Company

Bristol Myers Squibb Company

ViiV Healthcare

Johnson & Johnson

Allergan plc

Biohaven Pharmaceutical Holding Company Ltd.

Intercept Pharmaceuticals, Inc.

Vertex Pharmaceuticals Incorporated

Horizon Therapeutics plc

Genfit SA

Additional Topics

Approvals Market Intelligence Research & Development Launches BioPharmaceutical

More from New Products

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window